Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Other financing activities (2017 - 2025)

VitaNova Life Sciences (YJGJ) has disclosed Other financing activities for 6 consecutive years, with $500.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $500.0, compared with a TTM value of $2000.0 through Apr 2025, changed N/A, and an annual FY2025 reading of $2000.0, up 100.0% over the prior year.
  • Other financing activities was $500.0 for Q1 2025 at VitaNova Life Sciences, down from $750.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $17282.0 in Q3 2023 and bottomed at -$17282.0 in Q4 2023.
  • Average Other financing activities over 3 years is $400.0, with a median of $750.0 recorded in 2024.
  • Peak annual rise in Other financing activities hit 104.34% in 2024, while the deepest fall reached 95.66% in 2024.
  • Year by year, Other financing activities stood at -$17282.0 in 2023, then skyrocketed by 104.34% to $750.0 in 2024, then tumbled by 33.33% to $500.0 in 2025.
  • Business Quant data shows Other financing activities for YJGJ at $500.0 in Q1 2025, $750.0 in Q4 2024, and $750.0 in Q3 2024.